ZOTA NSE filing

Zota Health Care Ltd. recommends 10% final dividend, approves financial results.

The RealCase readMedium impact Positive

Zota Health Care Limited's Board approved standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. They recommended a final dividend of 10% (Re. 1 per share) for FY26. The company also approved acquiring shares in its subsidiary, Davaindia Health Mart Limited.

Why it matters

The dividend recommendation and financial results are material information for investors. The acquisition within a wholly-owned subsidiary is less impactful than an acquisition of an external entity but still relevant to the company's structure and strategy.

The market read

The announcement includes the approval of financial results and the recommendation of a dividend, which are generally positive for shareholders. The acquisition of shares in a wholly-owned subsidiary can also be viewed positively as it strengthens control and integration.

Zota Health Care Limited announced the outcome of its Board Meeting held on Friday, May 22, 2026. The Board considered and approved the Standalone and Consolidated Audited Financial Results for the quarter and year ended March 31, 2026, along with the Audit Reports, which received an unmodified opinion from the auditors, M/s. Pradeep K. Singhi & Associates.

The company also recommended a final dividend of 10%, equivalent to Re. 1/- per equity share of Rs. 10/- each, for the financial year 2025-26, subject to shareholder approval at the upcoming Annual General Meeting.

Furthermore, the Board approved the acquisition of 39,794 equity shares of its Wholly Owned Subsidiary, Davaindia Health Mart Limited, through a subscription to its right issue.

Filing to action

What to do with a filing like this

Zota Health Care LImited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Zota Health Care LImited. Read the original for the full detail.

View original filing